747 related articles for article (PubMed ID: 28239999)
21. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
[TBL] [Abstract][Full Text] [Related]
22. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
[TBL] [Abstract][Full Text] [Related]
23. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
[TBL] [Abstract][Full Text] [Related]
24. A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art.
Pinkiewicz M; Pinkiewicz M; Walecki J; Zawadzki M
Front Oncol; 2022; 12():950167. PubMed ID: 36212394
[TBL] [Abstract][Full Text] [Related]
25. Glioblastoma with Primitive Neuroectodermal Component Treated with Adjuvant Radiotherapy and Temozolomide: A Pooled Analysis of 23 Patients.
Benson R; Mallick S; Purkait S; Haresh KP; Gupta S; Sharma MC; Suri V; Sharma D; Rath GK
Neurol India; 2021; 69(4):856-860. PubMed ID: 34507401
[TBL] [Abstract][Full Text] [Related]
26. From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.
Elmaci I; Ozpinar A; Ozpinar A; Perez JL; Altinoz MA
Metab Brain Dis; 2019 Jun; 34(3):687-704. PubMed ID: 30937698
[TBL] [Abstract][Full Text] [Related]
27. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
Verdugo E; Puerto I; Medina MÁ
Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
[TBL] [Abstract][Full Text] [Related]
28. Exploring the role of Nrf2 signaling in glioblastoma multiforme.
Awuah WA; Toufik AR; Yarlagadda R; Mikhailova T; Mehta A; Huang H; Kundu M; Lopes L; Benson S; Mykola L; Vladyslav S; Alexiou A; Alghamdi BS; Hashem AM; Md Ashraf G
Discov Oncol; 2022 Sep; 13(1):94. PubMed ID: 36169772
[TBL] [Abstract][Full Text] [Related]
29. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar giant cell glioblastoma multiforme in an adult.
Mishra SS; Behera SK; Dhir MK; Senapati SB
J Neurosci Rural Pract; 2014 Jul; 5(3):295-7. PubMed ID: 25002780
[TBL] [Abstract][Full Text] [Related]
32. Glioblastoma multiforme: State of the art and future therapeutics.
Wilson TA; Karajannis MA; Harter DH
Surg Neurol Int; 2014; 5():64. PubMed ID: 24991467
[TBL] [Abstract][Full Text] [Related]
33. [Glioblastoma multiforme--new hope due to modern therapeutical approaches].
Gautschi OP; Cadosch D; Collen TD; Land M; Hoederath P; Hildebrandt G; Fournier JY; Hundsberger T
Praxis (Bern 1994); 2010 Mar; 99(5):295-308. PubMed ID: 20205087
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction.
Mallick S; Gandhi AK; Rath GK
Indian J Med Paediatr Oncol; 2015; 36(4):229-37. PubMed ID: 26811592
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.
Czarnywojtek A; Borowska M; Dyrka K; Van Gool S; Sawicka-Gutaj N; Moskal J; Kościński J; Graczyk P; Hałas T; Lewandowska AM; Czepczyński R; Ruchała M
Pharmacology; 2023; 108(5):423-431. PubMed ID: 37459849
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of concomitant radiotherapy in newly diagnosed glioblastoma multiforme: a multivariate analysis of 116 patients.
Okumus NO; Gursel B; Meydan D; Ozdemir O; Odabas E; Gonullu G
Ann Saudi Med; 2012; 32(3):250-5. PubMed ID: 22588435
[TBL] [Abstract][Full Text] [Related]
37. Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.
Donato V; Papaleo A; Castrichino A; Banelli E; Giangaspero F; Salvati M; Delfini R
Tumori; 2007; 93(3):248-56. PubMed ID: 17679459
[TBL] [Abstract][Full Text] [Related]
38. A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?
Rock K; McArdle O; Forde P; Dunne M; Fitzpatrick D; O'Neill B; Faul C
Br J Radiol; 2012 Sep; 85(1017):e729-33. PubMed ID: 22215883
[TBL] [Abstract][Full Text] [Related]
39. Canadian recommendations for the treatment of glioblastoma multiforme.
Mason WP; Maestro RD; Eisenstat D; Forsyth P; Fulton D; Laperrière N; Macdonald D; Perry J; Thiessen B;
Curr Oncol; 2007 Jun; 14(3):110-7. PubMed ID: 17593983
[TBL] [Abstract][Full Text] [Related]
40. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
